Using Medical Cannabis for Managing Pain in Charcot-Marie-Tooth Disease

by | Feb 23, 2023 | 1 comment

Using Medical Cannabis for Managing Pain in Charcot-Marie-Tooth Disease – Patient Reported Outcomes

Data regarding medical cannabis use for pain relief in CMT from HNF’s CMT Patient Registry, GRIN, was analyzed and published by a team lead by Brian J. Piper, PhD and  Gregory T. Carter, MD. The results revealed the vast majority of those surveyed experienced significant relief, providing evidence that controlled trials are needed to evaluate this pain treatment in CMT further.

Objective: Chronic pain is a major problem for patients with Charcot-Marie-Tooth (CMT) disease. This exploratory study examined patient-reported efficacy of medical cannabis for pain management in this population.


Learn more on this topic

Related Blog Posts

The Key Role CMT Patients Play in Research

The Key Role CMT Patients Play in Research

Without your participation, researchers won’t have the essential patient information to develop drugs, gene therapies, and clinical trials for Charcot-Marie-Tooth and other Inherited Neuropathies. In addition, as GRIN grows, we gain greater insights from you as patients to help accelerate therapies for Charcot-Marie-Tooth (CMT) and Inherited Neuropathies.

Cannabis & CBD for CMT

Join our experts, Meg D’Elia & Brian Piper, PhD along with CMT patient panelists as they provide research, insight and personal experience on the topic of medical marijuana.

Join the conversation

Leave a Comment

1 Comment

  1. Linda

    I have been taking CBD medically for about 1/2 year. I have CMT1A, but find no relief from the CBD for pain.But what the CBD what the CBD does is help with nightly restless legs and cramping. Since starting CBD I have experienced no restless legs and very few cramps. The cramps have not totally disappeared but the frequency and severity is much decreased.


Submit a Comment

Your email address will not be published. Required fields are marked *


Join for notifications on events, campaigns, & news